Ekso Bionics Holdings Inc (EKSO)

[Rhetorical]

It is only FDA approved for spinal cord patients, not stroke patients (I'm pretty sure about this, but not positive). The spinal cord market is beginning to reach saturation, but the stroke market has not.
It's much easier for a small company to double its earnings than a large one. So far the news hasn't affected PH stock price much (up <2% currently). I learned this the other day from a Peter Lynch video. It's also worth pointing out that PH stock is at a P.E. of 16 plus and has done worse than S&P 500 TR over the last 5 years.

(http://performance.morningstar.com/stock/performance-return.action?t=PH®ion=usa&culture=en-US)

Ultimately, I think this is a good thing. I think it means that Ekso's FDA approval is even more more likely if competition with less steps taken is able to be accepted. It's also an early start on working to get insurance companies to reimburse these devices, which will benefit Ekso as much as PH. It's hard to see another company get something you want, but I will be patient and hold out for something even better.